Remegen Biosciences Is A Biopharmaceutical Company Focused On Discovering And Developing Innovative Medicines For Cancer And Autoimmune Diseasesthe Company Utilizes Advanced Protein Engineering And Design Technologiesalong With Extensive Experience In Manufacturing And Clinical Developmentto Identify New Therapeutic Targets And Create Effective Biotherapeutics Remegen S Services Include Research And Development In Oncologyimmunologyand Ophthalmic Diseasesas Well As Clinical Development To Advance Promising Therapeutic Candidatesthe Company Has Developed Notable Products Such As Disitamab Vedotinrecognized As China S First Original Antibody Drug Conjugateand Telitacicepta First In Class Dual Target Fusion Protein For Autoimmune Diseasesremegen Operates In The United States With Locations In South San Franciscocaliforniaand Rockvillemarylandand Is A Wholly Owned Subsidiary Of Remegen Co
